Qube Research & Technologies LTD Bolt Biotherapeutics, Inc. Transaction History

Qube Research & Technologies LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.98 - $1.46 $1 - $2	2 New	2 $0
Q3 2022 Nov 14, 2022	SELL	$1.48 - $2.61 $1,756 - $3,098	-1,187 Reduced 5.8%	19,286 $29,000
Q2 2022 Aug 15, 2022	BUY	$1.41 - $2.91 $1,215 - $2,508	862 Added 4.4%	20,473 $42,000
Q1 2022 May 09, 2022	SELL	$2.74 - $4.82 $71,319 - $125,459	-26,029 Reduced 57.03%	19,611 $54,000
Q4 2021 Feb 01, 2022	BUY	$4.19 - $13.97 $128,373 - $428,012	30,638 Added 204.23%	45,640 $224,000
Q3 2021 Nov 12, 2021	BUY	$11.15 - $18.6 $167,272 - $279,037	15,002 New	15,002 $190,000

18.1M

Ticker BOLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,641,500
Market Cap $10.9M
Description
Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.